<code id='7DE007ACA6'></code><style id='7DE007ACA6'></style>
    • <acronym id='7DE007ACA6'></acronym>
      <center id='7DE007ACA6'><center id='7DE007ACA6'><tfoot id='7DE007ACA6'></tfoot></center><abbr id='7DE007ACA6'><dir id='7DE007ACA6'><tfoot id='7DE007ACA6'></tfoot><noframes id='7DE007ACA6'>

    • <optgroup id='7DE007ACA6'><strike id='7DE007ACA6'><sup id='7DE007ACA6'></sup></strike><code id='7DE007ACA6'></code></optgroup>
        1. <b id='7DE007ACA6'><label id='7DE007ACA6'><select id='7DE007ACA6'><dt id='7DE007ACA6'><span id='7DE007ACA6'></span></dt></select></label></b><u id='7DE007ACA6'></u>
          <i id='7DE007ACA6'><strike id='7DE007ACA6'><tt id='7DE007ACA6'><pre id='7DE007ACA6'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:248
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Roche's accidental data boosts hopes for anti
          Roche's accidental data boosts hopes for anti

          SEBASTIENBOZON/AFPviaGettyImagesThemultibillion-dollarhuntforwhatmanydrugmakershopewillbethenextbigi

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          What past blockbusters can tell us about future of Wegovy and other weight loss medicines

          MollyFergusonforSTATThenewsthattheweightlossdrugWegovyreducedtheriskofheartattacksandstrokesinoverwe